IX Biopharma (SGX: 42C) News & Headlines

Anson Properties ceased to be substantial shareholder of iX Biopharma

External newsYahoo Finance Singapore10 Sep 2026

42C Forecast — Price Target — Prediction for 2027

External newsTradingView8 Sep 2026

US Government Opens Emergency Use Pathway for iX Biopharma’s Wafermine

External newsMinichart8 Sep 2026

iX Biopharma Advances Wafermine EUA Submission After US Emergency Declaration

External newsMinichart7 Sep 2026

HOW IX BIOPHARMA TURNED CONVICTION INTO OPPORTUNITY

External newsCNA14 Aug 2026

Price to sales forward of iX Biopharma Ltd. – SGX:42C

External newsTradingView2 Aug 2026

Enterprise value to EBIT forward of iX Biopharma Ltd. – SGX:42C

External newsTradingView1 Aug 2026

Price to earnings forward of iX Biopharma Ltd. – SGX:42C

External newsTradingView1 Aug 2026

iX Biopharma Ltd. Revenue Breakdown – SGX:42C

External newsTradingView29 Jul 2026

iX Biopharma’s Rally Continues after an Institutional Vote of Confidence

External newsNextInsight28 Jul 2026

OCBC emerges as substantial shareholder of iX Biopharma

External newsThe Edge Singapore27 Jul 2026

IX Biopharma Reports 92% Warrants Exercise

External newsMoomoo16 Jul 2026

iX Biopharma allots close to 2.92 mil new shares following warrant exercise

External newsYahoo Finance Singapore14 Jul 2026

iX Biopharma Ltd. Actuals & Estimates (SGX:42C)

External newsTradingView27 Jun 2026

IX Biopharma to Relocate Manufacturing Equipment to US; Shares Fall 8%

External newsMoomoo16 Jun 2026

Number of shareholders of iX Biopharma Ltd. – SGX:42C

External newsTradingView13 Jun 2026

Pain relief for GI Joes, giant leap for iX Biopharma

External newsThe Edge Singapore5 Jun 2026

IX Biopharma Allots, Issues New Shares

External newsMoomoo22 May 2026

IX Biopharma Allots, Issues More Shares

External newsMoomoo12 May 2026

IX Biopharma Narrows Loss in Fiscal Q3

External newsMoomoo11 May 2026

IX Biopharma 42C

Latest news